Advertisement
Screener

CENCORA, INC. (COR) Retained Earnings

2.8 / 5 stars · 68/120 Roast Me

CENCORA, INC. Retained Earnings

CENCORA, INC. (COR) had Retained Earnings of $9.14 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent

us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-05

  • 2026-06-30: Retained Earnings (Accumulated Deficit) $9.14B.
  • 2026-03-31: Retained Earnings (Accumulated Deficit) $8.49B.
  • 2025-12-31: Retained Earnings (Accumulated Deficit) $6.97B.
  • 2025-09-30: Retained Earnings (Accumulated Deficit) $6.53B.
Period endRetained Earnings (Accumulated Deficit)Retained Earnings (Accumulated Deficit) as first filed
2026-06-30$9.14B
10-Q · filed 2026-08-05
2026-03-31$8.49B
10-Q · filed 2026-05-06
2025-12-31$6.97B
10-Q · filed 2026-02-04
2025-09-30$6.53B
10-Q · filed 2026-08-05
2025-06-30$6.98B
10-Q · filed 2025-08-06
2025-03-31$6.40B
10-Q · filed 2025-05-07
2024-12-31$5.79B
10-Q · filed 2025-02-05
2024-09-30$5.42B
8-K · filed 2026-02-10
2024-06-30$5.51B
10-Q · filed 2024-07-31
2024-03-31$5.13B
10-Q · filed 2024-05-01
2023-12-31$4.82B
10-Q · filed 2024-01-31
2023-09-30$4.32B
10-K · filed 2024-11-26
2023-06-30$4.07B
10-Q · filed 2023-08-02
2023-03-31$3.69B
10-Q · filed 2023-05-02
2022-12-31$3.36B
10-Q · filed 2023-02-01
2022-09-30$2.98B
10-K · filed 2023-11-21
2022-06-30$2.78B
10-Q · filed 2022-08-03
2022-03-31$2.47B
10-Q · filed 2022-05-04
2021-12-31$2.02B
10-Q · filed 2022-02-02
2021-09-30$1.67B
10-K · filed 2022-11-22
2021-06-30$1.33B
10-Q · filed 2021-08-04
2021-03-31$1.12B
10-Q · filed 2021-05-05
2020-12-31$780.97M
10-Q · filed 2021-02-04
2020-09-30$518.34M
10-K · filed 2021-11-23
2020-06-30$5.45B
10-Q · filed 2020-08-05
2020-03-31$5.25B
10-Q · filed 2020-05-07
2019-12-31$4.38B
10-Q · filed 2020-01-30
2019-09-30$4.24B
10-K · filed 2020-11-19
2019-06-30$4.19B
10-Q · filed 2019-08-01
2019-03-31$3.97B
10-Q · filed 2019-05-02
2018-12-31$4.03B
10-Q · filed 2019-01-31
2018-09-30$3.72B
10-K · filed 2019-11-19
2018-06-30$3.57B
10-Q · filed 2018-08-02
2018-03-31$3.38B
10-Q · filed 2018-05-02
2017-12-31$3.17B
10-Q · filed 2018-02-06
2017-09-30$2.40B
10-K · filed 2018-11-20
2017-06-30$2.82B
10-Q · filed 2017-08-03
2017-03-31$2.85B
10-Q · filed 2017-05-04
2016-12-31$2.52B
10-Q · filed 2017-01-31
2016-09-30$2.30B
10-K · filed 2017-11-21
2016-06-30$2.25B
10-Q · filed 2016-08-02
2016-03-31$1.97B
10-Q · filed 2016-05-05
2015-12-31$1.44B
10-Q · filed 2016-02-04
2015-09-30$1.16B
10-K · filed 2016-11-22
$1.18B
10-K · filed 2015-11-24
2015-06-30$879.20M
10-Q · filed 2015-08-06
2015-03-31$728.97M
10-Q · filed 2015-05-08
2014-12-31$1.31B
10-Q · filed 2015-02-06
2014-09-30$1.57B
10-K · filed 2015-11-24
2014-06-30$1.56B
10-Q · filed 2014-08-07
2014-03-31$1.62B
10-Q · filed 2014-05-07
2013-12-31$1.50B
10-Q · filed 2014-02-07
2013-09-30$1.51B
10-K · filed 2014-11-25
2013-06-30$1.51B
10-Q · filed 2013-08-07
2013-03-31$1.39B
10-Q · filed 2013-05-09
2012-12-31$1.39B
10-Q · filed 2013-02-08
2012-09-30$1.27B
10-K · filed 2013-11-26
2012-06-30$1.14B
10-Q · filed 2012-08-09
2012-03-31$990.99M
10-Q · filed 2012-05-10
2011-12-31$812.61M
10-Q · filed 2012-02-07
2011-09-30$4.06B
8-K · filed 2013-07-16
2011-06-30$3.94B
10-Q · filed 2011-08-08
2011-03-31$3.79B
10-Q · filed 2011-05-06
2010-12-31$3.60B
10-Q · filed 2011-02-08
2010-09-30$3.47B
10-K · filed 2011-11-22
2010-06-30$3.35B
10-Q · filed 2010-08-03
2010-03-31$3.21B
10-Q · filed 2010-05-07
2009-12-31$3.05B
10-Q · filed 2010-02-05
2009-09-30$2.92B
10-K · filed 2010-11-23
2009-06-30$2.81B
10-Q · filed 2009-08-06
2008-09-30$2.48B
10-K · filed 2009-11-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
CARDINAL HEALTH INC (CAH)United States$51.753B29.38
MCKESSON CORP (MCK)United States$101.317B19.78
HERBALIFE LTD. (HLF)$1.281B8.39
NU SKIN ENTERPRISES, INC. (NUS)United States$0.225B-1.18
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
HWH International Inc. (HWH)United States$0.021B-4.08
DataMeds AI, Inc. (MEDS)United States$0.011B